GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Truscreen Group Ltd (ASX:TRU) » Definitions » EV-to-EBITDA

Truscreen Group (ASX:TRU) EV-to-EBITDA : -7.52 (As of May. 30, 2025)


View and export this data going back to 2021. Start your Free Trial

What is Truscreen Group EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Truscreen Group's enterprise value is A$15.31 Mil. Truscreen Group's EBITDA for the trailing twelve months (TTM) ended in Mar. 2025 was A$-2.04 Mil. Therefore, Truscreen Group's EV-to-EBITDA for today is -7.52.

The historical rank and industry rank for Truscreen Group's EV-to-EBITDA or its related term are showing as below:

ASX:TRU' s EV-to-EBITDA Range Over the Past 10 Years
Min: -68.97   Med: -6.76   Max: -0.95
Current: -7.44

During the past 11 years, the highest EV-to-EBITDA of Truscreen Group was -0.95. The lowest was -68.97. And the median was -6.76.

ASX:TRU's EV-to-EBITDA is ranked worse than
100% of 494 companies
in the Medical Devices & Instruments industry
Industry Median: 15.78 vs ASX:TRU: -7.44

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2025-05-30), Truscreen Group's stock price is A$0.027. Truscreen Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 was A$-0.004. Therefore, Truscreen Group's PE Ratio (TTM) for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).


Truscreen Group EV-to-EBITDA Historical Data

The historical data trend for Truscreen Group's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Truscreen Group EV-to-EBITDA Chart

Truscreen Group Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only -10.92 -2.78 -3.37 -3.70 -7.45

Truscreen Group Semi-Annual Data
Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.37 - -3.70 - -7.45

Competitive Comparison of Truscreen Group's EV-to-EBITDA

For the Medical Devices subindustry, Truscreen Group's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Truscreen Group's EV-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Truscreen Group's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Truscreen Group's EV-to-EBITDA falls into.


;
;

Truscreen Group EV-to-EBITDA Calculation

Truscreen Group's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=15.312/-2.037
=-7.52

Truscreen Group's current Enterprise Value is A$15.31 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Truscreen Group's EBITDA for the trailing twelve months (TTM) ended in Mar. 2025 was A$-2.04 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Truscreen Group  (ASX:TRU) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Truscreen Group's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.027/-0.004
=At Loss

Truscreen Group's share price for today is A$0.027.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Truscreen Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 was A$-0.004.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).

Please read Which price ratio outperforms the enterprise multiple?


Truscreen Group EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Truscreen Group's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Truscreen Group Business Description

Traded in Other Exchanges
Address
C/- HLB Mann Judd Limited, 57 Symonds Street, Level 6, Equitable House, Grafton, Auckland, NZL, 1010
Truscreen Group Ltd is a medical device company. The company manufactures and distributes the Truscreen Cervical Cancer screening system which comprises a medical device and process designed to detect the presence in real-time of precancerous and cancerous tissue on the cervix. The product utilizes technology to detect the pre-cancerous change, or cervical intraepithelial neoplasia (CIN), by optical and electrical measurements of cervical tissue. Geographically, the company operates its business in New Zealand, Mexico, China, Russia, Zimbabwe, Vietnam, and other countries. Maximum revenue is generated from China.